| SPRINT BIOSCIENCE AB |
| Schweden |
| Gesundheit |
| SE0006343745 / A14NY2 |
| 5JA1 (Frankfurt) |
| FRA:5JA1, ETR:5JA1, 5JA1:GR |
| - |
| https://www.sprintbioscie.. |
|
Sprint Bioscience AB is a biotechnology company specializing in the early stages of drug development. The company's primary function is to accelerate the discovery and development of novel oncology pharmaceuticals. Utilizing state-of-the-art technolo..
>Volltext.. |
| 25.14 Mio. EUR |
| 13.48 Mio. EUR |
| 15.67 Mio. EUR |
| 9.22 Mio. EUR |
| 8.6 Mio. EUR |
| 0.08 EUR |
| - |
| 11.88 Mio. EUR |
| 7.83 Mio. EUR |
| 7.25 |
| 169.86% |
| - |
| - |
| - |
| - |
| - |
| SPRINT BIOSCIENCE, SPRINT BIO |
| 04.04.26 |
|